Point72 Asset Management
MRVI icon

Point72 Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Point72 Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.07M Buy
3,205,496
+357,697
+13% +$1.21M 0.01% 1314
2025
Q4 		$9.26M Buy
2,847,799
+2,815,057
+8,598% +$9.48M 0.01% 1405
2025
Q3 		$94K Buy
+32,742
New +$83.6K ﹤0.01% 2211
2024
Q4 		– Sell
-1,026,749
Closed -$8.53M – 2314
2024
Q3 		$8.53M Sell
1,026,749
-2,492,812
-71% -$21.5M 0.02% 698
2024
Q2 		$25.2M Buy
3,519,561
+2,109,199
+150% +$18.2M 0.07% 344
2024
Q1 		$12.2M Buy
1,410,362
+459,162
+48% +$3.11M 0.03% 643
2023
Q4 		$6.23M Buy
+951,200
New +$6.15M 0.02% 844
2023
Q3 		– Sell
-460,111
Closed -$5.72M – 2731
2023
Q2 		$5.72M Buy
+460,111
New +$6.21M 0.02% 769
2022
Q4 		– Sell
-151,000
Closed -$3.85M – 1694
2022
Q3 		$3.85M Buy
+151,000
New +$3.79M 0.02% 794
2022
Q1 		– Sell
-390,900
Closed -$13.1M – 1307
2021
Q4 		$16.4M Buy
390,900
+261,412
+202% +$10.6M 0.07% 379
2021
Q3 		$6.36M Buy
+129,488
New +$6.32M 0.03% 608
2021
Q1 		– Sell
-493,883
Closed -$13.9M – 1099
2020
Q4 		$13.9M Buy
+493,883
New +$13.8M 0.07% 366

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's MRVI Position: Q1 2026 in Review

Point72 Asset Management increased its Maravai LifeSciences (MRVI) stake by 13% in Q1 2026, buying an estimated $1.21M and bringing the position to 3,205,496 shares worth $9.07M. The position accounts for 0.01% of the portfolio, ranked #1314.

Point72 Asset Management first reported a position in MRVI in Q4 2020 and has held it in 12 quarters since. The position peaked at $25.2M in Q2 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Point72 Asset Management held 3,205,496 shares of Maravai LifeSciences worth $9.07M as of Q1 2026.
  • Point72 Asset Management bought 357,697 Maravai LifeSciences shares in Q1 2026, an estimated $1.21M.
  • Maravai LifeSciences made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1314 holding.
  • Point72 Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 12 quarters since.
  • Point72 Asset Management's Maravai LifeSciences position peaked at $25.2M in Q2 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.